Clinical Trial: A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus Erythematosus

U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07557927) titled 'A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus Erythematosus' on April 22.

Brief Summary: This study is a multicentre, randomised, double-blind, double-dummy, phase II clinical trial with a positive-control group, designed to evaluate the efficacy and safety of dihydroartemisinin tablets in the treatment of discoid lupus erythematosus (DLE).

Study Start Date: April 30

Study Type: INTERVENTIONAL

Condition: Discoid Lupus Erythematosus

Intervention: DRUG: Dihydroartemisinin tablets

Dihydroartemisinin 40mg, taken orally twice a day, f...